Birkbeck, University of London Featured PhD Programmes
The Francis Crick Institute Featured PhD Programmes
University of Kent Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
European Molecular Biology Laboratory (Heidelberg) Featured PhD Programmes
United Kingdom
Manchester×
10 miles

Cancer / Oncology PhD Projects, Programs & Scholarships in Manchester

We have 42 Cancer / Oncology PhD Projects, Programs & Scholarships in Manchester

  • Cancer / Oncology×
  • United Kingdom×
  • Manchester×
  • clear all
Order by 
Showing 1 to 10 of 42
  (MRC DTP) New strategies for immuno-PET radiochemistry
  Dr A McMahon, Dr M Fairclough, Prof K Williams
Application Deadline: 15 November 2019

Funding Type

PhD Type

Aims. To enhance immunoPET availability through. 1. Significant reduction in antibody usage. 2. Development of a secondary [18F]affibody approach applicable to all mAbs.
  (MRC DTP) Improved identification of brain tumour extent on advanced multi-modality medical images
  Dr R Hinz, Dr David Coope, Dr M Asselin, Prof A Jackson
Application Deadline: 15 November 2019

Funding Type

PhD Type

Gliomas are primary brain tumours which span a spectrum from comparatively slow growing tumours in young adults to highly aggressive tumours presenting later in life.
  (MRC DTP) What is the best way for healthcare professionals to communicate changes in estimated risk of breast cancer?
  Prof D French, Prof Anthony Howell, Dr L McWilliams, Prof G Evans
Application Deadline: 15 November 2019

Funding Type

PhD Type

Risk estimation models for common multifactorial diseases such as breast cancer are often used, e.g. in Family History Clinics to inform decisions about prevention options.
  (MRC DTP) Quantifying change in mammographic appearance using Artificial Intelligence
  Dr S Astley, Dr Yit Lim, Dr S Howell, Dr M Fergie
Application Deadline: 15 November 2019

Funding Type

PhD Type

Breast cancer is the most common cancer among women, with over 54,000 new cases diagnosed each year in the UK.
  (MRC DTP) Development of a risk model towards personalised screening for radiation-induced breast cancer using the national Breast Screening After Radiotherapy Dataset (BARD)
  Dr M Aznar, Dr S Howell, Dr S Astley, Prof J Radford
Application Deadline: 15 November 2019

Funding Type

PhD Type

Radiotherapy uses radiation (x-rays, protons) to kill cancer cells, and is an important part of cancer treatment for many patients.
  (MRC DTP) Determining potential targets to enhance radiotherapy treatment of cancer by activating the immune system
  Dr M Travis, Prof K Williams, Prof T Illidge
Application Deadline: 15 November 2019

Funding Type

PhD Type

Cancer causes more than one in four of all deaths in the UK, and despite recent advances in therapy, much more still needs to be done to identify new treatments, and to make existing treatments more effective.
  (MRC DTP) Modelling the impact on costs and outcomes on enhancing early detection in lung and colorectal cancers
  Prof A Renehan, Prof K Payne, Dr M Sperrin, Dr G P Martin
Application Deadline: 15 November 2019

Funding Type

PhD Type

Background. Cancer early detection (ED) and cancer health economics are key MRCR themes and central to the successful CRUK Manchester MERCADO award (includes Renehan & Payne).
  (MRC DTP) Glyphosate and N-nitrosoglyphosate toxicity in C. elegans
  Dr A Povey, Dr G Poulin
Application Deadline: 15 November 2019

Funding Type

PhD Type

Glyphosate (N-(phosphonomethyl)glycine). GLY) is a systemic herbicide that is in extensive worldwide use in agriculture, amenity and garden settings1.
  Chemotherapy dose-capping due to obesity and its impact on survival
  Prof A Renehan, Dr Jorge Barriuso
Applications accepted all year round

Funding Type

PhD Type

Obesity is associated with risk for several cancer types, including colorectal and breast cancers (1). Obesity also predicts for a poor outcome after cancer treatment.
  (MRC DTP) Exploiting tumour-promoting paracrine signals in solid cancers to turbocharge genetically redirected T cells
  Dr A Hurlstone, Prof R Edmondson
Application Deadline: 15 November 2019

Funding Type

PhD Type

Adoptive cell therapy (ACT) using tumour infiltrating lymphocytes (TILs) or genetically redirected T cells are some of the most promising approaches to emerge recently for the treatment of metastatic disease.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.